Literature DB >> 26197713

[Hemochromatosis].

B Oppl1, J Zwerina.   

Abstract

Hereditary hemochromatosis is a frequent autosomal recessive iron storage disease in northern and western Europe. The classical clinical triad of liver cirrhosis, hyperpigmentation and diabetes is nowadays rare, most probably because of early recognition. The homozygous C282Y mutation in the HFE gene is responsible for most cases of hereditary hemochromatosis, although other much rarer mutations in other genes have been recently identified. Progressive iron overload not only causes liver cirrhosis but also triggers development of a characteristic arthropathy. Bony swelling with intermittent arthritis of the second and third metacarpophalangeal joints is typical as well as occurrence of chondrocalcinosis in wrists and knee joints. The therapy of choice is excess iron removal by phlebotomy. Treatment usually prevents or even reverses liver damage but does not alter the course of hemochromatosis arthropathy.

Entities:  

Mesh:

Year:  2015        PMID: 26197713     DOI: 10.1007/s00393-015-1583-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  31 in total

1.  Prevalence of C282Y and H63D mutations in the haemochromatosis (HFE) gene in Tunisian population.

Authors:  R Sassi; Slama Hmida; H Kaabi; A Hajjej; A Abid; S Abdelkefi; S Yacoub; M Maamar; N Mojaat; L Ben Hamed; H Bellali; A Dridi; A Jridi; B Midouni; M K Boukef
Journal:  Ann Genet       Date:  2004 Oct-Dec

2.  EASL clinical practice guidelines for HFE hemochromatosis.

Authors: 
Journal:  J Hepatol       Date:  2010-04-18       Impact factor: 25.083

3.  Radiological features of the visceral and skeletal involvement of hemochromatosis.

Authors:  H J Jäger; U Mehring; G F Götz; M Neise; R Erlemann; H J Kapp; K D Mathias
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

Review 4.  Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.

Authors:  Antonello Pietrangelo
Journal:  Gastroenterology       Date:  2010-06-11       Impact factor: 22.682

5.  A population-based study of the clinical expression of the hemochromatosis gene.

Authors:  J K Olynyk; D J Cullen; S Aquilia; E Rossi; L Summerville; L W Powell
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

6.  Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.

Authors:  Roman Mayr; William J H Griffiths; Martin Hermann; Ian McFarlane; David J Halsall; Armin Finkenstedt; Andrew Douds; Susan E Davies; Andreas R Janecke; Wolfgang Vogel; Timothy M Cox; Heinz Zoller
Journal:  Gastroenterology       Date:  2011-03-09       Impact factor: 22.682

7.  Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.

Authors:  Felix Stickel; Stephan Buch; Heinz Zoller; Rolf Hultcrantz; Sabina Gallati; Christoph Österreicher; Armin Finkenstedt; Andreas Stadlmayr; Elmar Aigner; Enijad Sahinbegovic; Christoph Sarrazin; Clemens Schafmayer; Felix Braun; Wiebke Erhart; Michael Nothnagel; Markus M Lerch; Julia Mayerle; Henry Völzke; André Schaller; Wolfgang Kratzer; Bernhard O Boehm; Bence Sipos; Mauro D'Amato; Leif Torkvist; Per Stal; Alexander Arlt; Andre Franke; Thomas Becker; Michael Krawczak; Jochen Zwerina; Thomas Berg; Holger Hinrichsen; Elisabeth Krones; Christian Dejaco; Michael Strasser; Christian Datz; Jochen Hampe
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

8.  Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives.

Authors:  Maria Elmberg; Rolf Hultcrantz; Fereshte Ebrahim; Sigvard Olsson; Stefan Lindgren; Lars Lööf; Per Stål; Sven Wallerstedt; Sven Almer; Hanna Sandberg-Gertzén; Anders Ekbom; Johan Askling
Journal:  Gastroenterology       Date:  2009-07-18       Impact factor: 22.682

9.  Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.

Authors:  Edouard Bardou-Jacquet; Julie Philip; Richard Lorho; Martine Ropert; Marianne Latournerie; Pauline Houssel-Debry; Dominique Guyader; Olivier Loréal; Karim Boudjema; Pierre Brissot
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

10.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

View more
  1 in total

1.  Long-term Outcome of Orthotopic Liver Transplantation in Patients With Hemochromatosis: A Summary of a 30-year Transplant Program.

Authors:  Eva Maria Dobrindt; Eriselda Keshi; Julian Neulichedl; Wenzel Schöning; Robert Öllinger; Johann Pratschke; Dennis Eurich
Journal:  Transplant Direct       Date:  2020-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.